InvestorsHub Logo
Followers 34
Posts 2999
Boards Moderated 0
Alias Born 02/27/2016

Re: XenaLives post# 171595

Sunday, 11/11/2018 9:57:05 AM

Sunday, November 11, 2018 9:57:05 AM

Post# of 461195
A lot of competition out there.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021548/

There are 112 agents in the current AD treatment pipeline. There are 26 agents in 35 trials in phase III, 63 agents in 75 trials in phase II, and 23 agents in 25 trials in phase I. A review of the mechanisms of actions of the agents in the pipeline shows that 63% are disease-modifying therapies, 22% are symptomatic cognitive enhancers, and 12% are symptomatic agents addressing neuropsychiatric and behavioral changes.

Are we the one? It makes it hard to get investor’s attention and dollars with so many fighting for the same pool of money.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News